Ryan B. Rush

1.5k total citations
66 papers, 1.0k citations indexed

About

Ryan B. Rush is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Ryan B. Rush has authored 66 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Ophthalmology, 47 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Neurology. Recurrent topics in Ryan B. Rush's work include Retinal Diseases and Treatments (28 papers), Glaucoma and retinal disorders (19 papers) and Retinal and Macular Surgery (16 papers). Ryan B. Rush is often cited by papers focused on Retinal Diseases and Treatments (28 papers), Glaucoma and retinal disorders (19 papers) and Retinal and Macular Surgery (16 papers). Ryan B. Rush collaborates with scholars based in United States, Australia and India. Ryan B. Rush's co-authors include Sloan W. Rush, Matthew P. Simunovic, Xin‐Fu Zhou, Alex P. Hunyor, Mubariz Naqvi, Andrew Chang, J. Edward Ysasaga, Karen Chapman, Jason C. Smith and Mary Kay Irwin and has published in prestigious journals such as Journal of Neuroscience, Analytical Biochemistry and Pharmacology & Therapeutics.

In The Last Decade

Ryan B. Rush

62 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan B. Rush United States 19 674 604 106 103 102 66 1.0k
Hamid Riazi‐Esfahani Iran 16 540 0.8× 476 0.8× 53 0.5× 32 0.3× 37 0.4× 116 733
Hikmet Başmak Türkiye 18 499 0.7× 520 0.9× 87 0.8× 83 0.8× 20 0.2× 55 820
M. Baudrimont France 14 120 0.2× 174 0.3× 98 0.9× 21 0.2× 65 0.6× 39 643
R. Tipperman United States 10 253 0.4× 117 0.2× 60 0.6× 17 0.2× 46 0.5× 52 459
Jerome Sherman United States 17 534 0.8× 219 0.4× 78 0.7× 69 0.7× 72 0.7× 62 914
Levent Tök Türkiye 15 298 0.4× 201 0.3× 83 0.8× 76 0.7× 10 0.1× 36 519
Ahmed Awadein Egypt 13 211 0.3× 205 0.3× 30 0.3× 49 0.5× 29 0.3× 56 598
William Eric Sponsel United States 21 1.2k 1.7× 603 1.0× 32 0.3× 18 0.2× 28 0.3× 85 1.3k
Asaf Achiron Israel 17 557 0.8× 447 0.7× 23 0.2× 9 0.1× 17 0.2× 110 903
Du Tran-Viet United States 17 536 0.8× 644 1.1× 133 1.3× 213 2.1× 11 0.1× 37 804

Countries citing papers authored by Ryan B. Rush

Since Specialization
Citations

This map shows the geographic impact of Ryan B. Rush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan B. Rush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan B. Rush more than expected).

Fields of papers citing papers by Ryan B. Rush

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan B. Rush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan B. Rush. The network helps show where Ryan B. Rush may publish in the future.

Co-authorship network of co-authors of Ryan B. Rush

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan B. Rush. A scholar is included among the top collaborators of Ryan B. Rush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan B. Rush. Ryan B. Rush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rush, Ryan B., et al.. (2025). One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy. Clinical ophthalmology. Volume 19. 111–118. 1 indexed citations
3.
Rush, Ryan B., et al.. (2024). Real-World Outcomes in Pre-Existing Neovascular Age-Related Macular Degeneration Subjects Undergoing Avacincaptad Therapy for Geographic Atrophy. Clinical ophthalmology. Volume 18. 4011–4018. 1 indexed citations
4.
Rush, Ryan B.. (2023). One Year Results of Faricimab for Aflibercept-Resistant Diabetic Macular Edema. Clinical ophthalmology. Volume 17. 2397–2403. 21 indexed citations
5.
Rush, Sloan W., et al.. (2023). Patient-Reported Dry Eye Outcomes After Myopic Femtosecond-LASIK: A 6-Month Prospective Analysis. Clinical ophthalmology. Volume 17. 2141–2147. 6 indexed citations
6.
Rush, Sloan W., et al.. (2023). Topography-Guided LASIK: A Prospective Study Evaluating Patient-Reported Outcomes. Clinical ophthalmology. Volume 17. 2815–2824. 3 indexed citations
7.
Rush, Sloan W., Felix O. Omoruyi, & Ryan B. Rush. (2022). Patient Attitudes and Desirability Regarding Immediate Sequential Bilateral Cataract Surgery. Clinical ophthalmology. Volume 16. 1375–1381. 3 indexed citations
8.
Rush, Sloan W., et al.. (2019). Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trial. British Journal of Ophthalmology. 103(12). bjophthalmol–2018. 14 indexed citations
9.
Rush, Sloan W., et al.. (2018). Bevacizumab before Diabetic Vitrectomy. Ophthalmology Retina. 2(10). 1010–1020. 12 indexed citations
10.
Rush, Sloan W. & Ryan B. Rush. (2016). Outcomes of Infectious versus Sterile Perforated Corneal Ulcers after Therapeutic Penetrating Keratoplasty in the United States. Journal of Ophthalmology. 2016. 1–6. 12 indexed citations
11.
Rush, Sloan W. & Ryan B. Rush. (2016). Femtosecond laser-assisted phototherapeutic keratectomy for the treatment of dense corneal scarring. 2(1). 39–42. 1 indexed citations
12.
Rush, Sloan W., et al.. (2016). Corneal Epithelial Thickness Measured by Manual Electronic Caliper Spectral Domain Optical Coherence Tomography. Asia-Pacific Journal of Ophthalmology. 5(2). 147–150. 5 indexed citations
13.
Rush, Sloan W. & Ryan B. Rush. (2016). Epithelium-off versus transepithelial corneal collagen crosslinking for progressive corneal ectasia: a randomised and controlled trial. British Journal of Ophthalmology. 101(4). 503–508. 28 indexed citations
14.
Rush, Sloan W., et al.. (2015). Prospective analysis of outcomes and economic factors of same-day bilateral cataract surgery in the United States. Journal of Cataract & Refractive Surgery. 41(4). 732–739. 44 indexed citations
15.
Rush, Ryan B. & Sloan W. Rush. (2015). Ranibizumab Versus Bevacizumab for Neovascular Age-Related Macular Degeneration With an Incomplete Posterior Vitreous Detachment. Asia-Pacific Journal of Ophthalmology. 5(3). 171–175. 6 indexed citations
16.
Rush, Ryan B., et al.. (2013). Pars Plana Vitrectomy Versus Combined Pars Plana Vitrectomy–Scleral Buckle for Secondary Repair of Retinal Detachment. Ophthalmic surgery, lasers & imaging retina. 44(4). 374–379. 12 indexed citations
17.
Rush, Ryan B., et al.. (2013). TREAT-AND-EXTEND BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 34(5). 846–852. 24 indexed citations
18.
Simunovic, Matthew P., Ryan B. Rush, Alex P. Hunyor, & Andrew Chang. (2012). Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. British Journal of Ophthalmology. 96(6). 862–866. 87 indexed citations
19.
Rush, Ryan B. & Miles H. Friedlander. (2007). Alcaligenes xylosoxidans Conjunctivitis. Cornea. 26(7). 868–869. 1 indexed citations
20.
Rush, Ryan B., et al.. (1995). THE INFLUENCE OF THE RENIN ANGIOTENSIN SYSTEM ON ABNORMAL EXPRESSION OF NERVE GROWTH FACTOR IN THE SPONTANEOUSLY HYPERTENSIVE RAT. Clinical and Experimental Pharmacology and Physiology. 22(6-7). 478–480. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hamid Riazi‐Esfahani Breakdown of academic impact, for papers by Hikmet Başmak Breakdown of academic impact, for papers by M. Baudrimont Breakdown of academic impact, for papers by R. Tipperman Breakdown of academic impact, for papers by Jerome Sherman Breakdown of academic impact, for papers by Levent Tök Breakdown of academic impact, for papers by Ahmed Awadein Breakdown of academic impact, for papers by William Eric Sponsel Breakdown of academic impact, for papers by Asaf Achiron Breakdown of academic impact, for papers by Du Tran-Viet
Rankless by CCL
2026